Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

ISL1 controls pancreatic alpha cell fate and beta cell maturation

R. Bohuslavova, V. Fabriciova, L. Lebrón-Mora, J. Malfatti, O. Smolik, L. Valihrach, S. Benesova, D. Zucha, Z. Berkova, F. Saudek, SM. Evans, G. Pavlinkova

. 2023 ; 13 (1) : 53. [pub] 20230310

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Glucose homeostasis is dependent on functional pancreatic α and ß cells. The mechanisms underlying the generation and maturation of these endocrine cells remain unclear. RESULTS: We unravel the molecular mode of action of ISL1 in controlling α cell fate and the formation of functional ß cells in the pancreas. By combining transgenic mouse models, transcriptomic and epigenomic profiling, we uncover that elimination of Isl1 results in a diabetic phenotype with a complete loss of α cells, disrupted pancreatic islet architecture, downregulation of key ß-cell regulators and maturation markers of ß cells, and an enrichment in an intermediate endocrine progenitor transcriptomic profile. CONCLUSIONS: Mechanistically, apart from the altered transcriptome of pancreatic endocrine cells, Isl1 elimination results in altered silencing H3K27me3 histone modifications in the promoter regions of genes that are essential for endocrine cell differentiation. Our results thus show that ISL1 transcriptionally and epigenetically controls α cell fate competence, and ß cell maturation, suggesting that ISL1 is a critical component for generating functional α and ß cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002710
003      
CZ-PrNML
005      
20240624144032.0
007      
ta
008      
230413s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13578-023-01003-9 $2 doi
035    __
$a (PubMed)36899442
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bohuslavova, Romana $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia. romana.bohuslavova@ibt.cas.cz
245    10
$a ISL1 controls pancreatic alpha cell fate and beta cell maturation / $c R. Bohuslavova, V. Fabriciova, L. Lebrón-Mora, J. Malfatti, O. Smolik, L. Valihrach, S. Benesova, D. Zucha, Z. Berkova, F. Saudek, SM. Evans, G. Pavlinkova
520    9_
$a BACKGROUND: Glucose homeostasis is dependent on functional pancreatic α and ß cells. The mechanisms underlying the generation and maturation of these endocrine cells remain unclear. RESULTS: We unravel the molecular mode of action of ISL1 in controlling α cell fate and the formation of functional ß cells in the pancreas. By combining transgenic mouse models, transcriptomic and epigenomic profiling, we uncover that elimination of Isl1 results in a diabetic phenotype with a complete loss of α cells, disrupted pancreatic islet architecture, downregulation of key ß-cell regulators and maturation markers of ß cells, and an enrichment in an intermediate endocrine progenitor transcriptomic profile. CONCLUSIONS: Mechanistically, apart from the altered transcriptome of pancreatic endocrine cells, Isl1 elimination results in altered silencing H3K27me3 histone modifications in the promoter regions of genes that are essential for endocrine cell differentiation. Our results thus show that ISL1 transcriptionally and epigenetically controls α cell fate competence, and ß cell maturation, suggesting that ISL1 is a critical component for generating functional α and ß cells.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fabriciova, Valeria $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Lebrón-Mora, Laura $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Malfatti, Jessica $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Smolik, Ondrej $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Valihrach, Lukas $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Benesova, Sarka $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Zucha, Daniel $u Laboratory of Gene Expression, Institute of Biotechnology CAS, 25250, Vestec, Czechia
700    1_
$a Berkova, Zuzana $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, 14021, Prague, Czechia
700    1_
$a Saudek, Frantisek $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, 14021, Prague, Czechia
700    1_
$a Evans, Sylvia M $u Department of Pharmacology; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, La Jolla, CA, USA
700    1_
$a Pavlínková, Gabriela, $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, 25250, Vestec, Czechia. gpavlinkova@ibt.cas.cz $1 https://orcid.org/0000000256896577 $d 1966- $7 xx0319150
773    0_
$w MED00198696 $t Cell & bioscience $x 2045-3701 $g Roč. 13, č. 1 (2023), s. 53
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36899442 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20240624144030 $b ABA008
999    __
$a ok $b bmc $g 1922637 $s 1188917
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 53 $e 20230310 $i 2045-3701 $m Cell & bioscience $n Cell Biosci $x MED00198696
LZP    __
$a Pubmed-20230413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...